BioResearch Open Access is a peer-reviewed open access journal that provides a rapid-publication forum for a broad range of scientific topics including but not limited to molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience.
The Journal publishes basic science and translational research in the form of original research articles, comprehensive review articles, mini-reviews, rapid communications, brief reports, technology reports, hypothesis articles, perspectives, and letters to the editor. All articles in BioResearch Open Access are rapidly reviewed and published online within 4 weeks of acceptance. Articles are fully open access and deposited immediately in PubMed Central. BioResearch Open Access is fully NIH-, HHMI- and Wellcome Trust compliant.
Benefits of publishing in BioResearch Open Access:
- High visibility, immediate and unrestricted online access to published articles
- Broad coverage of biomedical research
- Rigorous and rapid peer review
- Easy compliance with open access mandates
- Authors retain copyright
- Highly indexed – citation tracking and inclusion in bibliographic databases
- Targeted email marketing
The Journal is under the leadership of Editor-in-Chief Robert Lanza, MD, Ocata Therapeutics Headquarters and Wake Forest University School of Medicine and seasoned journal editors as Section Editors. View the entire editorial board.
Editorial Office Contact:
Jane Taylor, PhD.
Senior Research Fellow
MRC Centre for Regenerative Medicine, University of Edinburgh
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.